Covered recipient · General Payments record
OZNY OLVERA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,320.41
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $405.15 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $194.06 | 8 |
| Lilly USA, LLC | $142.31 | 9 |
| Axsome Therapeutics, Inc. | $47.91 | 2 |
| Insulet Corporation | $20.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | $24.23 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148399099 | CMS |
| Axsome Therapeutics, Inc. | $23.68 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148399101 | CMS |
| Insulet Corporation | $20.87 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116808883 | CMS |
| Lilly USA, LLC | $10.93 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135916969 | CMS |
| Lilly USA, LLC | $15.07 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135876690 | CMS |
| Lilly USA, LLC | $6.73 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135922048 | CMS |
| Lilly USA, LLC | $20.37 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135909419 | CMS |
| Lilly USA, LLC | $18.10 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135922046 | CMS |
| Lilly USA, LLC | $20.31 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135898136 | CMS |
| Lilly USA, LLC | $21.87 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135916967 | CMS |
| Lilly USA, LLC | $7.84 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135852977 | CMS |
| Lilly USA, LLC | $21.09 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135939434 | CMS |
| Novo Nordisk Inc | $8.24 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100459378 | CMS |
| Novo Nordisk Inc | $10.27 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100614055 | CMS |
| Novo Nordisk Inc | $11.43 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100634173 | CMS |
| Novo Nordisk Inc | $24.55 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100589437 | CMS |
| Novo Nordisk Inc | $5.41 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100365057 | CMS |
| Novo Nordisk Inc | $6.28 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100388107 | CMS |
| Novo Nordisk Inc | $11.58 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100418094 | CMS |
| Novo Nordisk Inc | $116.30 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100257468 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.